12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Wednesday's pre-market session, several healthcare stocks experienced significant movements. Heart Test Laboratories, PaxMedica, NeuroOne Medical Tech, Apollomics, TC BioPharm, and Curis saw their stocks rise by 23.9%, 23.24%, 14.68%, 14.18%, 13.99%, and 12.32% respectively. Conversely, UpHealth, Alterity Therapeutics, Nexalin Technology, SILO Pharma, Acutus Medical, and TRACON Pharma faced declines of 20.2%, 15.97%, 15.52%, 11.96%, 10.44%, and 10.05% respectively.
November 22, 2023 | 1:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Apollomics shares rose 14.18% to $0.92, with a market cap of $81.9 million.
The increase in stock price suggests positive market activity that may influence short-term trading.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Curis stock rose 12.32% to $9.57, with a market cap of $56.3 million.
The notable rise in pre-market trading may lead to continued investor interest in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Heart Test Laboratories' stock rose 23.9% to $0.24, with a market cap of $5.3 million.
The significant pre-market gain suggests positive investor sentiment or reaction to recent news, which could lead to short-term price momentum.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
NeuroOne Medical Tech stock climbed 14.68% to $1.46, with a market cap of $34.8 million.
The pre-market uptick could indicate investor optimism, potentially leading to further short-term gains.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
PaxMedica shares increased by 23.24% to $0.99, with a market value of $1.0 million.
The sharp rise in pre-market indicates strong investor interest which may continue into the regular trading session.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
TC BioPharm shares increased by 13.99% to $0.57, with a market cap of $5.3 million.
The pre-market gain could reflect investor confidence, potentially affecting the stock's short-term performance.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Acutus Medical stock dropped 10.44% to $0.25, with a market value of $7.2 million.
The downward movement in pre-market could indicate a negative outlook, affecting the stock's short-term trajectory.
CONFIDENCE 90
IMPORTANCE 65
RELEVANCE 100
NEGATIVE IMPACT
Alterity Therapeutics shares fell 15.97% to $2.0, with a market cap of $8.1 million.
The pre-market decline suggests potential negative market reaction, possibly affecting the stock's short-term price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Nexalin Technology stock decreased by 15.52% to $0.31, with a market cap of $2.2 million.
The drop in pre-market trading could reflect investor concerns, potentially leading to a short-term negative trend.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
SILO Pharma stock fell 11.96% to $1.62, with a market cap of $5.0 million.
The pre-market decrease may signal short-term bearish sentiment among investors.
CONFIDENCE 90
IMPORTANCE 65
RELEVANCE 100
NEGATIVE IMPACT
TRACON Pharma stock declined by 10.05% to $0.2, with a market cap of $6.0 million.
The pre-market loss could be a sign of investor skepticism or a reaction to company-specific news, likely leading to a short-term price decline.
CONFIDENCE 90
IMPORTANCE 65
RELEVANCE 100
NEGATIVE IMPACT
UpHealth stock declined by 20.2% to $0.63, with a market cap of $10.8 million.
The significant pre-market drop may indicate negative sentiment or reactions to news, likely leading to a short-term downtrend.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100